| Clinical Neurology | Lifetime | 42 | US 16 | 99.86 |
| Medical Physiology | Lifetime | 218 | US 125 | 99.67 |
| Psychiatry and Mental health | Lifetime | 291 | US 145 | 99.10 |
| Neuroscience of Neurology | Lifetime | 236 | US 102 | 98.14 |
| Cognitive Neuroscience | Lifetime | 554 | US 286 | 98.71 |
| Medical Physiology | 2021-2025 | 153 | US 54 | 98.15 |
| Clinical Neurology | 2021-2025 | 92 | US 27 | 97.96 |
| Cognitive Neuroscience | 2021-2025 | 272 | US 111 | 95.08 |
| Psychiatry and Mental health | 2021-2025 | 283 | US 110 | 93.32 |
| Radiology, Nuclear Medicine and Imaging | 2021-2025 | 412 | US 153 | 91.69 |
| Parkinson's Disease Mechanisms and Treatments | Lifetime | 46 | US 17 | 99.80 |
| Amyotrophic Lateral Sclerosis Research | Lifetime | 16 | US 9 | 99.66 |
| Alzheimer's disease research and treatments | Lifetime | 95 | US 52 | 99.74 |
| Neuromodulation and Treatments for Neurological Disorders | Lifetime | 98 | US 34 | 99.46 |
| Neurological diseases and metabolism | Lifetime | 34 | US 12 | 99.45 |
| Dementia and Cognitive Impairment Research | Lifetime | 128 | US 64 | 99.57 |
| Genetic Neurodegenerative Diseases | Lifetime | 105 | US 36 | 99.16 |
| Advanced Neuroimaging Techniques and Applications | Lifetime | 142 | US 68 | 99.23 |
| Neurobiology of Language and Bilingualism | Lifetime | 79 | US 34 | 98.91 |
| Neurological and metabolic disorders | Lifetime | 59 | US 29 | 98.38 |
| Cerebrovascular and genetic disorders | Lifetime | 33 | US 10 | 98.26 |
| Botulinum Toxin and Related Neurological Disorders | Lifetime | 375 | US 153 | 97.91 |
| Epilepsy research and treatment | Lifetime | 777 | US 323 | 97.04 |
| Language Development and Disorders | Lifetime | 330 | US 172 | 96.60 |
| Neurological Disease Mechanisms and Treatments | Lifetime | 658 | US 231 | 95.00 |
| Neurogenetic and Muscular Disorders Research | Lifetime | 755 | US 282 | 94.18 |
| Prion Diseases and Protein Misfolding | Lifetime | 716 | US 244 | 91.38 |
| Glycogen Storage Diseases and Myoclonus | Lifetime | 776 | US 243 | 89.45 |
| Autoimmune Neurological Disorders and Treatments | Lifetime | 590 | US 149 | 87.62 |
| Parkinson's Disease and Spinal Disorders | Lifetime | 604 | US 183 | 77.80 |
| Neurology and Historical Studies | Lifetime | 927 | US 378 | 75.45 |
| Hallucinations in medical conditions | Lifetime | 413 | US 94 | 56.84 |
| Alzheimer's disease research and treatments | 2021-2025 | 204 | US 91 | 97.76 |
| Parkinson's Disease Mechanisms and Treatments | 2021-2025 | 192 | US 48 | 97.42 |
| Neurobiology of Language and Bilingualism | 2021-2025 | 55 | US 22 | 95.82 |
| Advanced Neuroimaging Techniques and Applications | 2021-2025 | 224 | US 68 | 95.53 |
| Dementia and Cognitive Impairment Research | 2021-2025 | 335 | US 148 | 97.07 |
| Amyotrophic Lateral Sclerosis Research | 2021-2025 | 143 | US 37 | 94.07 |
| Genetics and Neurodevelopmental Disorders | 2021-2025 | 627 | US 214 | 87.03 |
| Neuromodulation and Treatments for Neurological Disorders | 2021-2025 | 702 | US 178 | 90.20 |
| Language Development and Disorders | 2021-2025 | 214 | US 82 | 88.21 |
| Voice and Speech Disorders | 2021-2025 | 455 | US 163 | 84.29 |
| Neurological diseases and metabolism | 2021-2025 | 278 | US 59 | 79.47 |
| Neurological and metabolic disorders | 2021-2025 | 126 | US 28 | 77.26 |
| S100 Proteins and Annexins | 2021-2025 | 570 | US 126 | 68.66 |
| Stuttering Research and Treatment | 2021-2025 | 347 | US 163 | 53.18 |
| Cerebrovascular and genetic disorders | 2021-2025 | 873 | US 153 | 28.00 |
